Physician profile
Josephine E Spitzley
NPI 1659719060
$1,629.97
in general payments reported to CMS, 2019-2025
21 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2020: $106 · 2021: $36.56 · 2022: $137 · 2023: $463 · 2024: $448 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $929 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $929.20 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $304.81 | 2019-2023 | Liletta |
| Femselect INC. | $199.80 | 2023-2024 | Enplace |
| Astellas Pharma US INC | $192.43 | 2023-2024 | Veozah |
| Lupin INC. | $158.83 | 2019-2020 | |
| Exeltis, USA INC. | $106.03 | 2022-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $93.17 | 2020-2024 | |
| Hologic Sales and Service, LLC | $92.54 | 2020-2024 | Acessa Provu System, Novasure, Fluent Fluid Management System |
| Aspira Women'S Health INC | $74.36 | 2023-2025 | Ova1 |
| Sumitomo Pharma America, INC. | $71.70 | 2023-2024 | Myfembree, Gemtesa |
| Coloplast Corp | $56.16 | 2023 | Saffron |
| Minerva Surgical, INC | $45.55 | 2019-2024 | |
| Organon LLC | $43.26 | 2024-2025 | Nuvaring, Nexplanon |
| Daiichi Sankyo INC. | $36.23 | 2022-2023 | Injectafer |
| Coopersurgical, INC. | $33.49 | 2024-2025 | Paragard T 380a |
| Biogen, INC. | $25.43 | 2025 | Zurzuvae |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $20.13 | 2019 | |
| Myovant Sciences INC. | $19.45 | 2021 | |
| Medtronic, INC. | $19.07 | 2023 | Truclear |
| Alexion Pharmaceuticals, INC. | $17.46 | 2019 | |
| Amag Pharmaceuticals, INC. | $12.36 | 2019 | |
| Meditrina | $7.71 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Josephine Spitzley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.